• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain

    Jordan Process Receives Nutrasource ICAP Certification for CBD

    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements

    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support

    Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain

    Jordan Process Receives Nutrasource ICAP Certification for CBD

    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support

    Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan

    Solvay Invests in Suanfarma’s Vanillin Production
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain

    Jordan Process Receives Nutrasource ICAP Certification for CBD

    Senate Bill to Reauthorize FDA User Fees Includes Dietary Supplement Listing Provision

    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements

    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain

    FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements

    Nootropics and Adaptogens Respond to Demand for Mind and Mood Support

    Experts Debate Role of Supplements in Improving Public Health in EU

    GNC Adds Products from The Honest Company, Hers, and Womaness
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    PhytoGaia Inc

    Nutrition21, LLC

    Xsto Solutions

    Botanic Healthcare LLC

    Gencor
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    PhytoGaia Inc

    Nutrition21, LLC

    Xsto Solutions

    Botanic Healthcare LLC

    Gencor
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Blog

    24 Years After DSHEA, Industry Still Lacks ODI Clarity

    An FDA-sanctioned database would alleviate uncertainty about the regulatory status of many dietary ingredients.

    24 Years After DSHEA, Industry Still Lacks ODI Clarity
    Related CONTENT
    • How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?
    • NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act
    • FDA Issues NAC Enforcement Discretion Guidance
    • FDA on NAC: Safety Profile Warrants Enforcement Discretion
    • NAC Supplements Could be Banned Unless FDA Reverses Course
    By Duffy MacKay, ND, Senior Vice President, Scientific & Regulatory Affairs, Council for Responsible Nutrition04.02.18
    True or false: Companies ready to put a new product to market have clear direction on the status of ingredients.
     
    This seems simple enough. Old dietary ingredients (ODIs) are dietary ingredients marketed in the United States before Oct. 15, 1994, when the Dietary Supplement Health and Education Act (DSHEA) was enacted. Juxtaposed with new dietary ingredients (NDIs), which require manufacturers to submit a pre-market notification to FDA at least 75 days before a dietary supplement is marketed, ODIs are not subject to this pre-market review. Super easy and clear, right?
     
    Wrong. Under the current system, companies have limited resources and often no way of knowing if an ingredient is an ODI. A heavy burden on manufacturers, especially those new to the industry, the absence of an authoritative list of ingredients exempt from NDI notifications forces companies to dig up old evidence such as advertisements, marketing brochures, scientific literature, and internal documents in order to provide the necessary evidence required by FDA before a product hits store shelves.
     
    Info on ‘Identity’
    There are thousands of common vitamins, minerals, botanicals, and other ingredients that were indisputably on the market pre-DSHEA. However, a 1993 magazine ad marketing chamomile may not be enough to get the green light from regulators. FDA suggests it would need to receive information that describes the “identity” of the ingredient, such as the plant part, type of extract (water, alcohol, etc.), the ingredient source, or the manufacturing method.
     
    But how many of us have 24-year-old documents at our disposal? Do you have a way to open the files on that eight-inch floppy you found buried in a box somewhere? Do you have immediate access to a microfilm reader? To assume companies would have maintained these types of records is unreasonable, which is why a publicly available, FDA-sanctioned database of ODIs would alleviate the uncertainty and burden of gathering proof for companies, allowing them to have clarity about dietary ingredients. So, what’s the holdup?
     
    Back in 1994, after DSHEA passed, the leading industry trade associations and their members compiled lists of ingredients the new law had declared “grandfathered.” Unfortunately, in the 2011 NDI Draft Guidance, FDA stated that in the absence of supporting evidence, these lists were not enough to serve as an authoritative resource. This decision spurred a diverse set of opinions regarding the best path forward among stakeholders. Has too much time passed to be able to provide FDA with sufficient evidence to make a meaningful list? If a company does have access to the requested evidence, will they use it as an opportunity to make money instead of sharing it openly? Perhaps industry does not have an obligation to do anything and the burden of gathering documentation is instead FDA’s?
     
    Creating Clarity
    We’ve had a quarter of a century to think this over. Generally supportive of FDA’s willingness to develop a pre-DSHEA ingredient list, industry recognizes such a list would not only benefit supplement manufacturers, but FDA—and even consumers—as well, so long as it is appropriately crafted and tailored in collaboration with stakeholders.
     
    FDA’s current efforts toward developing an ODI list is an opportunity to create clarity as to the regulatory status of a wide variety of dietary ingredients, but CRN calls for something more: a list that includes the entire universe of ingredients that do not require NDI notification. This family of ingredients includes:

    • Pre-DSHEA ingredients
    • NDIs filed with no objection since Oct. 15, 1994
    • Unaltered ingredients in the food supply
    Of course, all finished dietary ingredients are required by the Food, Drug, and Cosmetic Act to be safe and free of adulteration. Even with products that include ingredients exempt from notification, manufacturers are bound by law to evaluate the safety of finished products. Still, a more complete list of ingredients from FDA would eliminate the laborious and redundant processes currently facing companies and would allow FDA to better focus its regulatory and enforcement priorities.
     
    Considering the stakeholder input it has received over the past two and a half decades, FDA is now tasked with conducting a close investigation of the resources available and evaluating the pros and cons of moving forward on this project. In the meantime, the current NDI draft guidance remains the agency’s most current thinking on the topic, and companies would be wise to follow those processes. If a company is unsure about whether an ingredient needs notification, CRN suggests consulting a trade association, a regulatory attorney, or FDA directly. If you ask, you may not like the answer, but at least there will be clarity.

    Duffy MacKay, ND, is the senior vice president, scientific & regulatory affairs, Council for Responsible Nutrition (CRN), a leading trade association for the dietary supplement and functional food industry.
    Related Searches
    • Regulatory
    • vitamins
    • Adulteration
    • crn
    Related Knowledge Center
    • Dietary Supplements
    • Regulations
    Suggested For You
    How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain? How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?
    NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act
    FDA Issues NAC Enforcement Discretion Guidance FDA Issues NAC Enforcement Discretion Guidance
    FDA on NAC: Safety Profile Warrants Enforcement Discretion FDA on NAC: Safety Profile Warrants Enforcement Discretion
    NAC Supplements Could be Banned Unless FDA Reverses Course NAC Supplements Could be Banned Unless FDA Reverses Course
    NPA Appoints Douglas Kalman, PhD, as Director of Scientific Affairs NPA Appoints Douglas Kalman, PhD, as Director of Scientific Affairs
    Mushroom-Derived Vitamin D Source Receives Regulatory Approval in Brazil Mushroom-Derived Vitamin D Source Receives Regulatory Approval in Brazil
    Laws and Policies Need to Transform to Meet Evolving Health Challenges Laws and Policies Need to Transform to Meet Evolving Health Challenges
    TSI’s MyHMB Becomes First USP-Verified Ingredient of Its Kind TSI’s MyHMB Becomes First USP-Verified Ingredient of Its Kind
    Biden Nominates Dr. Robert Califf to Lead FDA Biden Nominates Dr. Robert Califf to Lead FDA
    Understanding Exclusion (Preclusion) and a Proposed Solution Understanding Exclusion (Preclusion) and a Proposed Solution
    FDA Stance on CBD Requires Congress to Intervene FDA Stance on CBD Requires Congress to Intervene
    Review Breaks Down Lutein, Zeaxanthin Bioavailability in Eyes Review Breaks Down Lutein, Zeaxanthin Bioavailability in Eyes
    Formulating for Success in the Surging Dietary Supplement Market Formulating for Success in the Surging Dietary Supplement Market
    Federal Court Dismisses Lawsuit Aimed at Self-Affirmed GRAS Process Federal Court Dismisses Lawsuit Aimed at Self-Affirmed GRAS Process

    Related Content

    • Dietary Supplements | Herbs & Botanicals | World Markets
      How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?

      How Will China’s Immunity Gap Impact the Dietary Ingredients Supply Chain?

      Disruptions will continue. Plan early, plan often, and plan long.
      By Wilson Lau, President, Nuherbs 05.11.22

    • Dietary Supplements | Regulations
      NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act

      NPA Letter Spells Out Perceived Failings of Proposed Dietary Supplement Listing Act

      Daniel Fabricant, NPA president and CEO, lays out ‘grave concerns’ with mandatory product listing bill in message to Sens. Durbin and Braun.
      By Mike Montemarano, Associate Editor 04.29.22

    • Dietary Supplements | Proteins, Peptides, Amino Acids | Regulations
      FDA Issues NAC Enforcement Discretion Guidance

      FDA Issues NAC Enforcement Discretion Guidance

      The agency maintains NAC was first approved as a new drug before it was marketed as a dietary supplement, but may issue a rule following NPA request.
      By Mike Montemarano, Associate Editor 04.21.22


    • Dietary Supplements | Proteins, Peptides, Amino Acids | Regulations
      FDA on NAC: Safety Profile Warrants Enforcement Discretion

      FDA on NAC: Safety Profile Warrants Enforcement Discretion

      In a response to citizen petitions, the agency said it might undertake rulemaking and has found no safety concerns.
      By Mike Montemarano, Associate Editor 04.04.22

    • Dietary Supplements | Proteins, Peptides, Amino Acids | Regulations
      NAC Supplements Could be Banned Unless FDA Reverses Course

      NAC Supplements Could be Banned Unless FDA Reverses Course

      Warning letters from July 2020 have set off a firestorm, and the stakes are high for medical professionals, patients, and nutraceutical companies.
      By Erik Goldman, Holistic Primary Care 03.02.22

      Breaking News
      • Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
      • Jordan Process Receives Nutrasource ICAP Certification for CBD
      • FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements
      • Nootropics and Adaptogens Respond to Demand for Mind and Mood Support
      • Sabinsa Honors 70th Anniversary of Diplomacy Between India and Japan
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
      Jordan Process Receives Nutrasource ICAP Certification for CBD
      FDA Warns About Steroids or Steroid-Like Substances in Bodybuilding Supplements
      Coatings World

      Latest Breaking News From Coatings World

      AGM Secures Exclusive Distribution Agreement with Indian Partner Imkemex
      Microban Announced as Lead Sponsor of BCF Annual Conference and Dinner 2022
      DIC’s Indian Subsidiary Begins Construction of Coating Resins Production Facility
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Robocath Presents Results from R-Evolution Clinical Study
      Medtronic's Resolute Onyx Drug-Eluting Stent Shows Success for Left Main PCI
      Medtronic Shares 3-Year Renal Denervation Blood Pressure Trial Data
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Emergent CDMO Case Studies: Project Design & Implementation of Fill/Finish Technologies
      Aptar Pharma Launches HeroTracker Sense
      MasterControl Features Quality Management and Manufacturing Execution Systems
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Mielle Organics Welcomes Steve Pamon to Advisory Board
      Makeup Revolution Expands into Walgreens
      Nu Skin Joins EcoBeautyScore Consortium
      Happi

      Latest Breaking News From Happi

      Revolution Beauty Expands Makeup Revolution Into Walgreens
      Barentz Develops Electronic Personal Care Product Guide
      P&G Temporarily Closes Downtown Cincinnati Office Due to Potential Security Concerns
      Ink World

      Latest Breaking News From Ink World

      Nazdar Ink Technologies to Showcase Latest Ink Innovations at FESPA Global Print Expo 2022
      Epson Introduces First Direct-to-Fabric Printer for North America
      ProAmpac Facilities Secure Safety Awards 2022
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      In-Mold Decorating Association announces 2022 IMDA Awards Competition
      Essentra Packaging invests in Landa Nanographic press
      Nazdar to manufacture VFP electronic ink for US Market
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      'Right' Hygiene Conference to be Held in June
      Freudenberg to Present Battery Pack and Liquid Absorbers at Battery Show
      H&V Appoints Vice President and General Counsel
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Envista To Acquire Osteogenics
      Exactech Earns Breakthrough Status for JointMedica's Polymotion Hip Resurfacing
      Orthotic Brace Suppliers Convicted in $6.5M Fraud Scheme
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Emerson Earns Third Consecutive 2022 ENERGY STAR Partner of the Year Award
      First Solar to Sell Japan Project Development, O&M Platforms to PAG Real Assets
      Jabil Strengthens Additive Manufacturing Offerings

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login